These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33725205)

  • 1. ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis.
    Nakanishi R; Oki E; Hasuda H; Sano E; Miyashita Y; Sakai A; Koga N; Kuriyama N; Nonaka K; Fujimoto Y; Jogo T; Hokonohara K; Hu Q; Hisamatsu Y; Ando K; Kimura Y; Yoshizumi T; Mori M
    Ann Surg Oncol; 2021 Jun; 28(6):2986-2987. PubMed ID: 33725205
    [No Abstract]   [Full Text] [Related]  

  • 2. Who Will Benefit? Using Radiomics to Predict Response to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases.
    Hewitt DB; Pawlik TM; Cloyd JM
    Ann Surg Oncol; 2021 Jun; 28(6):2931-2933. PubMed ID: 33475881
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based Chemotherapy.
    Nakanishi R; Oki E; Hasuda H; Sano E; Miyashita Y; Sakai A; Koga N; Kuriyama N; Nonaka K; Fujimoto Y; Jogo T; Hokonohara K; Hu Q; Hisamatsu Y; Ando K; Kimura Y; Yoshizumi T; Mori M
    Ann Surg Oncol; 2021 Jun; 28(6):2975-2985. PubMed ID: 33454878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chemotherapy with S-1 and oxaliplatin (SOX) in combination with molecular-targeting agents on colorectal liver metastases.
    Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
    Anticancer Res; 2013 Sep; 33(9):3941-6. PubMed ID: 24023332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASO Author Reflection: Systemic Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy with Oxaliplatin in Patients with Colorectal Peritoneal Metastases.
    Lurvink RJ; Rovers KP; de Hingh IHJT; Deenen MJ
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):799-800. PubMed ID: 32602062
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Fong's Score in the Era of Modern Strategies for Metastatic Colorectal Cancer.
    Turpin A; Hebbar M
    Ann Surg Oncol; 2020 Mar; 27(3):886. PubMed ID: 31720930
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Colorectal Liver Metastases Early Progression After Chemotherapy: A Possible Contraindication to Surgery?
    Torzilli G; Viganò L
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):525-526. PubMed ID: 30511094
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naïve Patients with Liver Metastases from Colorectal Cancer.
    Larsen FO; Jensen BV; Nørgaard HH; Hermann HK; Larsen PN; Markussen A; Hogdall E; Nielsen D
    Oncology; 2019; 96(6):299-308. PubMed ID: 30999314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of capecitabine and oxaliplatin in metastatic colorectal cancer.
    Clin Colorectal Cancer; 2003 Feb; 2(4):205-9. PubMed ID: 12620138
    [No Abstract]   [Full Text] [Related]  

  • 10. Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
    Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
    Anticancer Res; 2013 Sep; 33(9):4029-32. PubMed ID: 24023346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
    Kim HR; Min BS; Kim JS; Shin SJ; Ahn JB; Rho JK; Kim NK; Rha SY
    Oncology; 2011; 81(3-4):175-83. PubMed ID: 22057187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of addition of bevacizumab to oxaliplatin-based preoperative chemotherapy in colorectal cancer with liver metastasis- a single institution experience.
    Cvetanovic A; Vrbic S; Filipovic S; Pejcic I; Milenkovic D; Milenkovic N; Zivkovic N
    J BUON; 2013; 18(3):641-6. PubMed ID: 24065477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perioperative Chemotherapies for Patients with Colorectal Liver Metastasis].
    Okazaki S; Ishikawa T; Uetake H
    Gan To Kagaku Ryoho; 2020 Apr; 47(4):574-577. PubMed ID: 32389954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 1 study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases.
    Takahashi M; Hasegawa K; Oba M; Saiura A; Arita J; Sakamoto Y; Shinozaki E; Mizunuma N; Matsuyama Y; Kokudo N
    Invest New Drugs; 2016 Aug; 34(4):468-73. PubMed ID: 27155613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of XPD Asp312Asn polymorphism and response to oxaliplatin-based first-line chemotherapy and survival in patients with metastatic colorectal cancer.
    Liu Z; Kong J; Kong Y; Cai F; Xu X; Liu J; Wang S
    Adv Clin Exp Med; 2019 Nov; 28(11):1459-1468. PubMed ID: 31756062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study.
    Le Roy B; Tixier L; Pereira B; Sauvanet P; Buc E; Pétorin C; Déchelotte P; Pezet D; Balayssac D
    PLoS One; 2016; 11(2):e0148739. PubMed ID: 26859833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiological heterogeneity in response to chemotherapy is associated with poor survival in patients with colorectal liver metastases.
    van Kessel CS; Samim M; Koopman M; van den Bosch MA; Borel Rinkes IH; Punt CJ; van Hillegersberg R
    Eur J Cancer; 2013 Jul; 49(11):2486-93. PubMed ID: 23692811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highlights from: the American Society of Clinical Oncology Gastrointestinal Cancers Symposium, Hollywood, FL, January 2005.
    Reddy GK; Gibson TB; Peck S; Tyagi P
    Clin Colorectal Cancer; 2005 Mar; 4(6):367-74. PubMed ID: 15807928
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analyses of Relapsed Cases after Oxaliplatin-Based Adjuvant Chemotherapy for Colorectal Cancer with Cur A Resection].
    Yoshimatsu K; Satake M; Sano M; Kodera A; Imaizumi R; Ito Y; Koike T; Yokomizo H; Yano Y; Okayama S; Yamada Y; Asaka S; Usui T; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Naritaka Y
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1519-1520. PubMed ID: 30382064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic chemotherapy and its implications for resection of colorectal liver metastasis.
    Robinson S; Manas DM; Pedley I; Mann D; White SA
    Surg Oncol; 2011 Jun; 20(2):57-72. PubMed ID: 19962301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.